Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BDTX

Black Diamond Therapeutics (BDTX)

Black Diamond Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BDTX
DateTimeSourceHeadlineSymbolCompany
14/05/202409:09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BDTXBlack Diamond Therapeutics Inc
09/05/202421:30GlobeNewswire Inc.Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
09/05/202421:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDTXBlack Diamond Therapeutics Inc
09/05/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
25/04/202406:05GlobeNewswire Inc.Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
11/04/202422:00GlobeNewswire Inc.Black Diamond Therapeutics Announces Changes to Board of DirectorsNASDAQ:BDTXBlack Diamond Therapeutics Inc
08/04/202408:00GlobeNewswire Inc.Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
03/04/202423:00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BDTXBlack Diamond Therapeutics Inc
12/03/202423:00GlobeNewswire Inc.Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
12/03/202404:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BDTXBlack Diamond Therapeutics Inc
06/03/202408:30GlobeNewswire Inc.Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024NASDAQ:BDTXBlack Diamond Therapeutics Inc
29/02/202400:00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:BDTXBlack Diamond Therapeutics Inc
16/02/202409:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
16/02/202409:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
16/02/202409:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
16/02/202409:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
15/02/202402:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BDTXBlack Diamond Therapeutics Inc
19/01/202408:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
05/01/202400:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
05/01/202400:00GlobeNewswire Inc.Black Diamond Therapeutics Announces Corporate Update and Expected 2024 MilestonesNASDAQ:BDTXBlack Diamond Therapeutics Inc
13/12/202323:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
13/12/202323:00GlobeNewswire Inc.Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBMNASDAQ:BDTXBlack Diamond Therapeutics Inc
08/11/202300:00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BDTXBlack Diamond Therapeutics Inc
06/11/202323:45GlobeNewswire Inc.Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
06/11/202323:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDTXBlack Diamond Therapeutics Inc
06/11/202323:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
15/10/202303:30GlobeNewswire Inc.Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535NASDAQ:BDTXBlack Diamond Therapeutics Inc
05/10/202303:14GlobeNewswire Inc.Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:BDTXBlack Diamond Therapeutics Inc
19/09/202307:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
18/09/202321:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BDTX

Your Recent History